CBE Stock Overview
Produces and sells perfumes, aromas, and natural products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for CBE from our risk checks.
Robertet SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €785.00 |
| 52 Week High | €875.00 |
| 52 Week Low | €710.00 |
| Beta | 0.33 |
| 11 Month Change | -5.42% |
| 3 Month Change | 9.77% |
| 1 Year Change | 0.38% |
| 33 Year Change | -16.26% |
| 5 Year Change | -2.36% |
| Change since IPO | 8,154.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBE | FR Chemicals | FR Market | |
|---|---|---|---|
| 7D | -0.6% | -2.4% | -2.1% |
| 1Y | 0.4% | 1.9% | -2.1% |
Return vs Industry: CBE underperformed the French Chemicals industry which returned 2.3% over the past year.
Return vs Market: CBE exceeded the French Market which returned -1.9% over the past year.
Price Volatility
| CBE volatility | |
|---|---|
| CBE Average Weekly Movement | 5.4% |
| Chemicals Industry Average Movement | 5.4% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.3% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: CBE has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: CBE's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1850 | 2,153 | Jerome Bruhat | www.robertet.com |
Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in four segments: Raw materials, Fragrances, Flavors, and Active Ingredients. It also produces organic essential oils and active ingredients.
Robertet SA Fundamentals Summary
| CBE fundamental statistics | |
|---|---|
| Market cap | €1.81b |
| Earnings (TTM) | €86.35m |
| Revenue (TTM) | €759.29m |
21.0x
P/E Ratio2.4x
P/S RatioIs CBE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBE income statement (TTM) | |
|---|---|
| Revenue | €759.29m |
| Cost of Revenue | €336.45m |
| Gross Profit | €422.84m |
| Other Expenses | €336.49m |
| Earnings | €86.35m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 41.34 |
| Gross Margin | 55.69% |
| Net Profit Margin | 11.37% |
| Debt/Equity Ratio | 61.8% |
How did CBE perform over the long term?
See historical performance and comparison